| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/2010 | US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof |
| 09/02/2010 | US20100222430 Method of Treating Post-Surgical Acute Pain |
| 09/02/2010 | US20100222429 Enzymatic Methods and Enzymes |
| 09/02/2010 | US20100222428 Fatty Acid Nutritional Supplement |
| 09/02/2010 | US20100222427 Pharmaceutical composition comprising oseltamivir phosphate |
| 09/02/2010 | US20100222426 Anti-Bacterial Agents |
| 09/02/2010 | US20100222425 Compositions and treatment methods-2 |
| 09/02/2010 | US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby |
| 09/02/2010 | US20100222423 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation |
| 09/02/2010 | US20100222422 Dietary supplements containing extracts of aronia and methods of using same to promote weight loss |
| 09/02/2010 | US20100222421 Usage of Baicalein in the Preparation of a Pharmaceutical Composition for the Treatment of Traumatic Brain Injury |
| 09/02/2010 | US20100222420 Compositions and methods for inhibiting ezh2 |
| 09/02/2010 | US20100222419 Method to inhibit cell growth using oligonucleotides |
| 09/02/2010 | US20100222418 Combination Products For Treating Cancer |
| 09/02/2010 | US20100222417 Compostions and methods for enhancing oligonucleotide delivery across and into epithelial tissues |
| 09/02/2010 | US20100222416 Diagnostic Marker and Therapeutic Target for Cancer |
| 09/02/2010 | US20100222415 Method to Diagnose, Predict Treatment Response and Develop Treatment for Psychiatric Disorders Using Markers |
| 09/02/2010 | US20100222414 SiRNA Sequence-Independent Modification Formats for Reducing Off-Target Phenotypic Effects in RNAi, and Stabilized Forms Thereof |
| 09/02/2010 | US20100222413 Chemically Modified Oligonucleotides for Use in Modulating Micro RNA and Uses Thereof |
| 09/02/2010 | US20100222412 Modulation of glucocorticoid receptor expression |
| 09/02/2010 | US20100222411 Vhz for diagnosis and treatment of cancer |
| 09/02/2010 | US20100222410 Nuclease compositions and methods |
| 09/02/2010 | US20100222409 Compositions and methods for inhibiting expression of pro-apoptotic genes |
| 09/02/2010 | US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis |
| 09/02/2010 | US20100222406 T Type Calcium Channel Blockers and the Treatment of Diseases |
| 09/02/2010 | US20100222405 Magnesium salts of hmg-coa reductase inhibitors |
| 09/02/2010 | US20100222404 Indazole derivative dihydrochloride |
| 09/02/2010 | US20100222403 Micogel Topical Formulations |
| 09/02/2010 | US20100222402 Method of manufacturing 4'-[[4-methyl-6-(1-methyl-1h-benzimidazol-2-yl)-2-propyl-1h-benzimidazol-1yl]methyl]biphenyl-2-carboxylic acid (telmisartan) |
| 09/02/2010 | US20100222401 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 09/02/2010 | US20100222400 F1F0-ATPase Inhibitors and Related Methods |
| 09/02/2010 | US20100222399 Thiazolidinedione Analogues For The Treatment Of Hypertension |
| 09/02/2010 | US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/02/2010 | US20100222396 4-aryl-butane-1,3-diamides |
| 09/02/2010 | US20100222395 Compounds capable of activating cholinergic receptors |
| 09/02/2010 | US20100222394 Method for producing pyrazol-3-yl-benzamide derivative |
| 09/02/2010 | US20100222393 Muscarinic receptor antagonists |
| 09/02/2010 | US20100222391 Benzimidazole compound crystal |
| 09/02/2010 | US20100222390 Methods and Compositions for the Intravenous Administration of Compounds Related to Proton Pump Inhibitors |
| 09/02/2010 | US20100222388 Enhanced Migraine Treatments Based on Ghrelin Mimetics |
| 09/02/2010 | US20100222387 3-Fluoro-Piperidine T-Type Calcium Channel Antagonists |
| 09/02/2010 | US20100222386 Substituted piperidines |
| 09/02/2010 | US20100222385 Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist |
| 09/02/2010 | US20100222384 Iminosugars and methods of treating arenaviral infections |
| 09/02/2010 | US20100222383 Iminosugars and methods of treating viral diseases |
| 09/02/2010 | US20100222382 Esters of Compounds in the Leptomycin Family |
| 09/02/2010 | US20100222381 Cyclopentathiophene/cyclohexathiophene DNA methyltransferase inhibitors |
| 09/02/2010 | US20100222380 Modified Chalcone Compounds as Antimitotic Agents |
| 09/02/2010 | US20100222379 Novel histone deacetylase inhibitors |
| 09/02/2010 | US20100222378 2-heteroarylcarboxylic acid amides |
| 09/02/2010 | US20100222377 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors |
| 09/02/2010 | US20100222376 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders |
| 09/02/2010 | US20100222375 Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day Administration |
| 09/02/2010 | US20100222374 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/02/2010 | US20100222373 Crystalline Form of Bis [(E)-7-[4-(4-fluoro-phenyl)-6-isopropyl-2-[methyl(methyl-sulfonyl)amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid] Calcium Salt |
| 09/02/2010 | US20100222372 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient |
| 09/02/2010 | US20100222371 Prevention of surgical adhesions |
| 09/02/2010 | US20100222370 Methods of Treating Cancer |
| 09/02/2010 | US20100222369 Treatment for dry eye conditions |
| 09/02/2010 | US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 09/02/2010 | US20100222367 Pyrazine kinase inhibitors |
| 09/02/2010 | US20100222366 Piperidine derivatives as modulators of chemokine receptor activity |
| 09/02/2010 | US20100222365 Substituted triazole deriviatives as oxytocin antagonists |
| 09/02/2010 | US20100222364 Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia |
| 09/02/2010 | US20100222363 Bicyclic Derivatives as P38 Inhibitors |
| 09/02/2010 | US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives |
| 09/02/2010 | US20100222361 2-acylaminothiazole derivative or salt thereof |
| 09/02/2010 | US20100222360 Treatment of Malignant Peripheral Nerve Sheath Tumors |
| 09/02/2010 | US20100222359 Compositions, synthesis, and methods of utilizing quinazolinedione derivatives |
| 09/02/2010 | US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| 09/02/2010 | US20100222357 Indol-3-y-carbonyl-piperidin and piperazin-derivatives |
| 09/02/2010 | US20100222356 Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents |
| 09/02/2010 | US20100222355 Quinolizidinone m1 receptor positive allosteric modulators |
| 09/02/2010 | US20100222354 AMPA Receptor Antagonists and Aldose Reductase Inhibitors for Neuropathic Pain |
| 09/02/2010 | US20100222353 Aminophthalazine derivative compounds |
| 09/02/2010 | US20100222352 Compounds and Methods for the Treatment of Viruses and Cancer |
| 09/02/2010 | US20100222350 Phenyl, pyridine, quinoline, isoquinoline, naphthyridine and pyrazine derivatives |
| 09/02/2010 | US20100222349 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 09/02/2010 | US20100222348 Quinolinone derivatives as parp inhibitors |
| 09/02/2010 | US20100222347 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 09/02/2010 | US20100222346 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 09/02/2010 | US20100222345 Novel compounds as antagonists or inverse agonists for opioid receptors |
| 09/02/2010 | US20100222344 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors |
| 09/02/2010 | US20100222343 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 09/02/2010 | US20100222342 Pyrrolopyrazole, potent kinase inhibitors |
| 09/02/2010 | US20100222341 Piperidine and piperazine derivatives |
| 09/02/2010 | US20100222340 SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES |
| 09/02/2010 | US20100222339 Thiazole pyrazolopyrimidines CRF1 receptor antagonists |
| 09/02/2010 | US20100222338 Beta-secretase modulators and methods of use |
| 09/02/2010 | US20100222336 Single enantiomer beta-agonists, methods for the production thereof and the use thereof as medication |
| 09/02/2010 | US20100222335 Process For The Preparation Of N,N'-Disubstituted Oxabispidines |
| 09/02/2010 | US20100222334 Pharmaceutical Formulation of Valsartan |
| 09/02/2010 | US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors |
| 09/02/2010 | US20100222331 New compounds |
| 09/02/2010 | US20100222330 New Compounds |
| 09/02/2010 | US20100222329 2-acylaminothiazole derivative or salt thereof |
| 09/02/2010 | US20100222328 2-cyclopropyl-thiazole derivatives |
| 09/02/2010 | US20100222327 Methods of Preparing Pharmaceutical Compositions Comprising Eslicarbazepine Acetate and Methods of Use |
| 09/02/2010 | US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders |
| 09/02/2010 | US20100222325 Inhibitors of Bruton's Tyrosine Kinase |